JSP
BIVV

Jackson Square Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Jackson Square Partners’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,107,110
Closed -$114M – 94
2017
Q4 		$114M Buy
2,107,110
+366,503
+21% +$20.1M 0.58% 35
2017
Q3 		$99.3M Sell
1,740,607
-116,849
-6% -$6.84M 0.48% 42
2017
Q2 		$112M Sell
1,857,456
-62,706
-3% -$3.57M 0.57% 32
2017
Q1 		$105M Buy
+1,920,162
New +$94.6M 0.51% 43

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Jackson Square Partners's BIVV Position: Q1 2018 in Review

Jackson Square Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 2,107,110 shares — an estimated $114M sold.

Jackson Square Partners first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $114M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Jackson Square Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Jackson Square Partners sold 2,107,110 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $114M.
  • Jackson Square Partners first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Jackson Square Partners's Bioverativ Inc. Common Stock position peaked at $114M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Jackson Square Partners's 13F filing for Q1 2018, filed 14 May 2018.